About Technology Issues FAQ

Links

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial

Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trial — Distribution of the number of citations over years.

site/software © exaly; All materials licenced under CC by-SA.